teriparatide

This simple and convenient dosage form could expand the market for parathyroid hormone (PTH) analogs such as teriparatide to considerably more than $1 billion.

Health News from Medical News Today 2009

They suggested that osteoblast-stimulating drugs such as teriparatide (Forteo) might be a better choice, though that too would have to be confirmed in future studies.

MedPageToday.com - medical news plus CME for physicians 2009

Osteoporosis was selected for the first human trial of the device because the active ingredient of the drug involved, teriparatide, is particularly suited to more precise delivery.

Implanted Microchip Shows Promise in Delivering Drugs Ron Winslow 2012

The active ingredient of teriparatide is hermetically sealed in powder form in tiny wells on the chip.

Implanted Microchip Shows Promise in Delivering Drugs Ron Winslow 2012

But scientists have discovered that a daily injection of a hormone – teriparatide – showed “miraculous” results in turning back the clock of bone mending.

Osteoporisis Drug ‘Miraculously’ Boosts Healing Of Fractured Bones | Impact Lab 2009

The researchers, who presented their findings at the Orthopaedic Research Society conference in the USA, revealed that of 145 patients who had an unhealed bone fracture – half of them for six months or longer – 93 per cent showed significant healing and pain control after being on teriparatide for only eight to 12 weeks.

Osteoporisis Drug ‘Miraculously’ Boosts Healing Of Fractured Bones | Impact Lab 2009

At the heart of the research is a form of teriparatide known as Forteo, which was approved for the treatment of osteoporosis in 2002.

Osteoporisis Drug ‘Miraculously’ Boosts Healing Of Fractured Bones | Impact Lab 2009

I had patients with severe osteoporosis, in tremendous pain from multiple fractures throughout their spine and pelvis, who I would put on teriparatide.

Osteoporisis Drug ‘Miraculously’ Boosts Healing Of Fractured Bones | Impact Lab 2009

"Increases in both vertebral and femoral strength in postmenopausal osteoporotic women after 18 months of treatment with teriparatide" was an 18-month, open-label study using finite element analysis of quantitative CT scans to analyze the effects of treatment with FORTEO on vertebral and proximal femoral strength.

unknown title 2011

"Increases in both vertebral and femoral strength in postmenopausal osteoporotic women after 18 months of treatment with teriparatide."

unknown title 2011